Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs Amoxicillin-clavulanic Acid in Acute Bacterial Sinusitis
NCT00174694Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2004
- Primary completion
- Dec 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 4 trial of telithromycin in acute bacterial sinusitis (ABS), sponsored by Sanofi. Started Nov 2004; status: completed.
02
Drugs
telithromycin
03
Conditions
acute bacterial sinusitis (ABS)
Beyond the preview
Go deeper on NCT00174694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174694.